Additionally, suppressing the catalytic activity of Src by DNAJB4, which functions as an endogenous Src inhibitor, can downregulate EGFR, FAK, and STAT3 downstream signaling pathways, leading to inhibition of epithelial–mesenchymal transition (EMT) and metastasis of lung cancer cells [77]. Here, EGFR is linked to lung carcinoma.